Adults with pulmonary arterial hypertension using vs. not using GLP-1 receptor agonists had significantly lower relative ...

An 82-year-old woman with a history of congestive heart failure was admitted to this hospital for volume overload. Ascites, ...

Death rates and disability in newborn PAH have declined globally since 1990, but inequalities remain, according to a 30-year ...

The addition of sotatercept, an activin-signaling inhibitor, to background therapy results in a lower risk for clinical worsening among adults with pulmonary arterial hypertension (PAH) who were ...

Pulmonary arterial hypertension (PAH) is a rare condition that's difficult to treat. The hallmarks of the disease—narrowing ...

Climate change exacerbates health emergencies, affecting outcomes and healthcare access due to natural disasters like ...